NCT01359358

Brief Summary

This project has as general objective to determine if there is any Methicillin-resistant Staphylococcus aureus (MRSA) strain disseminating in the hospital of Belo Horizonte. If this is the case, the investigators will determine if this is an international known strain by typing it by PFGE and MLST. The detection of mecA gene will be performed by PCR. Their susceptibility profile to several drugs will also be accessed and it will be possible to compare the response to those drugs commonly in use to that of Daptomycin, a new drug available in Brazil. It will be screened for reduced susceptibility to vancomycin by Macromethod Etest (MET) in order to search for VISA or hetero-VISA. Also, due to the discussions at the literature about mutations in genes that are said to be responsible for reduced susceptibility to vancomycin, the investigators will sequence these genes in all PFGE type strain of this study looking for mutations already described to compare to the screening results.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 24, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2011

Completed
Last Updated

May 24, 2011

Status Verified

May 1, 2011

First QC Date

May 20, 2011

Last Update Submit

May 23, 2011

Conditions

Keywords

MRSAMLSTPFGEResistanceisolated from colonization

Eligibility Criteria

Age1 Month+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MRSA from infection or from colonization of a patient who was already infected by MRSA during the time of the study

You may qualify if:

  • MRSA from infection sites
  • MRSA from colonization of the patients who already was infected by MRSA during the time of the study

You may not qualify if:

  • MRSA from colonization of a patient who has not infection caused by MRSA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Física de Sao Carlos - Universidade de Sao Paulo

São Carlos, São Paulo, 13560-590, Brazil

Location

Study Officials

  • Ilana L B Camargo, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hyllo Baeta MArcelo Jr, Master degree

CONTACT

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 20, 2011

First Posted

May 24, 2011

Study Start

July 1, 2011

Last Updated

May 24, 2011

Record last verified: 2011-05

Locations